Janux Therapeutics Inc. (JANX)
44.34
-1.01 (-2.23%)
At close: Jan 15, 2025, 12:29 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 19.20M | 51.43M | 35.58M | 7.81M | 658.00K |
| Short-Term Investments | 324.82M | 275.59M | 339.38M | n/a | n/a |
| Long-Term Investments | n/a | 816.00K | 816.00K | n/a | n/a |
| Other Long-Term Assets | 3.33M | 1.39M | 392.00K | -155.00K | -21.00K |
| Receivables | n/a | n/a | n/a | 8.00M | n/a |
| Inventory | n/a | -700.00K | -200.00K | n/a | n/a |
| Other Current Assets | 5.21M | 5.42M | 4.11M | 498.00K | n/a |
| Total Current Assets | 349.24M | 332.44M | 377.02M | 16.06M | 658.00K |
| Property-Plant & Equipment | 27.84M | 29.36M | 1.60M | 155.00K | 21.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 31.17M | 31.57M | 2.81M | 155.00K | 21.00K |
| Total Assets | 380.41M | 364.01M | 379.82M | 16.22M | 679.00K |
| Account Payables | 2.42M | 2.16M | 2.46M | 428.00K | 267.00K |
| Deferred Revenue | 1.71M | 5.41M | 5.16M | 1.95M | n/a |
| Short-Term Debt | 1.52M | 1.53M | 388.00K | n/a | 4.00M |
| Other Current Liabilities | 7.39M | 7.42M | 4.79M | 803.00K | 360.00K |
| Total Current Liabilities | 13.03M | 16.51M | 12.80M | 3.18M | 4.63M |
| Long-Term Debt | 23.02M | 49.08M | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | -24.54M | n/a | 21.62M | n/a |
| Total Long-Term Liabilities | 23.02M | 26.76M | 700.00K | 27.67M | 4.00M |
| Total Liabilities | 36.06M | 43.27M | 13.50M | 30.86M | 8.62M |
| Total Debt | 24.54M | 25.30M | 194.00K | n/a | 4.00M |
| Common Stock | 46.00K | 42.00K | 41.00K | 1K | 1K |
| Retained Earnings | -168.76M | -110.47M | -47.41M | -14.74M | -7.96M |
| Comprehensive Income | 665.00K | -1.53M | -270.00K | -21.62M | -4.00M |
| Shareholders Equity | 344.35M | 320.74M | 366.33M | -14.64M | -7.94M |
| Total Investments | 324.82M | 275.59M | 339.38M | n/a | n/a |